The Indian Council of Medical Research (ICMR) has validated TrueNat - a tuberculosis testing machine for COVID-19 screening tests.
On Thursday, the ICMR had updated its testing strategy for COVID-19.
The revised strategy states that asymptomatic direct and high-risk contacts of a confirmed case should be tested once between "day 5 and day 14" of coming in his/her contact.
Testing of all symptomatic individuals, who have undertaken international travel in the last 14 day, all symptomatic contacts of laboratory-confirmed cases, all symptomatic health care workers and all patients with severe acute respiratory illness (fever and cough and/or shortness of breath) will be done.
It will also be done in hotspots/cluster (as per the Ministry of Health and Family Welfare) and in large migration gatherings/ evacuees centres.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app